Industry sponsor
NeuroRx, Inc.
2 registered trials on this registry. An industry sponsor is running trials with a view to approval and sale.
2
Registered trials
0
Recruiting
1
In Phase 3
1
With results posted
Working on
Substances
Trials
All 2 trials
| Trial | Status | Phase | Substance | Sites |
|---|---|---|---|---|
| NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar DepressionNCT03396601 · NeuroRx, Inc. | Unknown status | Phase 3 | ketamine | 2 |
| Sequential Therapy for the Treatment of Severe Bipolar Depression.NCT02974010 · NeuroRx, Inc. | Completed | Phase 2 | ketamine | 4 |
Sponsor attribution is the lead sponsor recorded on ClinicalTrials.gov API v2. Collaborators are not counted here. Data build 2026-08-25.